Skip to main content

and
  1. Article

    Open Access

    Methylation across the central dogma in health and diseases: new therapeutic strategies

    The proper transfer of genetic information from DNA to RNA to protein is essential for cell-fate control, development, and health. Methylation of DNA, RNAs, histones, and non-histone proteins is a reversible p...

    Ruochen Liu, Erhu Zhao, Huijuan Yu, Chaoyu Yuan in Signal Transduction and Targeted Therapy (2023)

  2. Article

    Open Access

    Phase separation of DDX21 promotes colorectal cancer metastasis via MCM5-dependent EMT pathway

    RNA binding proteins (RBPs) contributes to cancer progression, but the underlying mechanism reminds unclear. Here, we find that DDX21, a representative RBP, is highly expressed in colorectal cancer (CRC), whic...

    Huabin Gao, Huiting Wei, Yang Yang, Hui Li, Jiangtao Liang, Jiecheng Ye in Oncogene (2023)

  3. Article

    Open Access

    Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer

    Tamoxifen resistance remains a clinical problem in estrogen receptor (ER)-positive breast cancer. SUMOylation of ERα enhances ERα-induced transcription activity. Tripartite motif-containing (TRIM) proteins are...

    Runyi Ye, NiJiati AiErken, **aying Kuang, Huijuan Zeng, Nan Shao, Ying Lin in Oncogenesis (2021)

  4. No Access

    Article

    A novel HDGF-ALCAM axis promotes the metastasis of Ewing sarcoma via regulating the GTPases signaling pathway

    Ewing sarcoma (ES) is a type of highly aggressive pediatric tumor in bones and soft tissues and its metastatic spread remains the most powerful predictor of poor outcome. We previously identified that the tran...

    Yang Yang, Yuedong Ma, Huabin Gao, Tingsheng Peng, Huijuan Shi, Yunxiang Tang in Oncogene (2021)

  5. Article

    Open Access

    Overexpression of PSAT1 regulated by G9A sustains cell proliferation in colorectal cancer

    Huijuan Wang, Longzhen Cui, Dandan Li, Ming Fan in Signal Transduction and Targeted Therapy (2020)